News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Newton Todd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Newton Todd (Director) has filed a Form 4 on MIMEDX GROUP, INC.|
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
| 09/19/2022 |
4
| Newton Todd (Interim CEO) has filed a Form 4 on MIMEDX GROUP, INC.|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Granted 77,075 shares
@ $0
Granted 115,094 options to buy
@ $2.08, valued at
$239.4k
|
|
| 01/06/2020 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Acquired 3,296 shares
@ $0 |
|
| 08/14/2019 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Bought options to buy
@ $3.25, valued at
$0 |
|
| 06/28/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/14/2019 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Bought 25,000 shares
@ $3.534, valued at
$88.4k
Granted 3,600 shares
@ $3.5418, valued at
$12.8k
|
|
| 05/10/2019 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Granted 31,250 shares
@ $0
Granted 48,673 options to buy
@ $3.49, valued at
$169.9k
|
|
| 06/22/2018 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Bought 72,727 shares
@ $5.5, valued at
$400k
|
|
| 03/02/2018 |
4
| Newton Todd (CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Granted 28,750 shares
@ $0
Granted 86,250 options to buy
@ $6.58, valued at
$567.5k
|
|
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/03/2014 |
4
| Newton Todd (EVP, CFO & COO) has filed a Form 4 on ARTHROCARE CORP|
Txns:
| Disposed/sold 229,279 shares
@ $48.25, valued at
$11.1M
Disposed/sold 329 shares
@ $48.25, valued at
$15.9k
Exercised 17,020 options to buy
@ $23.5, valued at
$400k
Exercised 3,758 options to buy
@ $33.39, valued at
$125.5k
Exercised 3,806 options to buy
@ $26.24, valued at
$99.9k
Exercised 3,276 options to buy
@ $35.76, valued at
$117.1k
Exercised 13,280 options to buy
@ $23.5, valued at
$312.1k
Exercised 62,980 options to buy
@ $23.5, valued at
$1.5M
Exercised 14,575 options to buy
@ $33.39, valued at
$486.7k
Exercised 19,379 options to buy
@ $26.24, valued at
$508.5k
Exercised 25,273 options to buy
@ $35.76, valued at
$903.8k
|
|
| 06/21/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2012 |
4
| Newton Todd (SVP, CFO & COO) has filed a Form 4 on ARTHROCARE CORP|
Txns:
| Granted 9,457 shares
@ $0.001, valued at
$9.5
Bought 4,000 shares
@ $26.2, valued at
$104.8k
Granted 3,806 options to buy
@ $26.24, valued at
$99.9k
Granted 19,379 options to buy
@ $26.24, valued at
$508.5k
|
|
| 02/22/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2009 |
3
| Newton Todd (Sr VP and CFO) has filed a Form 3 on ARTHROCARE CORP |
|
|